24/7 Patient Assistance: 760-405-8205

Mark Scholz, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Asbestosis Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

  • Bio & Insurance Information

    Dr. Mark Scholz is a medical oncology specialist in Marina Del Rey, California and he works at St. John's Health Center. He got his diploma from Creighton University School of Medicine and did his residency in internal medicine at the University of Southern California - LAC+USC Medical Center, where he also completed a fellowship in medical oncology. The doctor is certified in internal medicine and medical oncology and has an experience of more than 20 years.



  • Education & Training

    dept_icon

    Creighton University School of Medicine

    Medical School

    dept_icon

    University of Southern California - LAC+USC Medical Center

    Residency

    dept_icon

    University of Southern California - LAC+USC Medical Center

    Fellowship

  • Board Certifications

    American Board of Internal Medicine

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    Providence Saint John's Health Center

    Languages: English/Spanish

    (310) 829-5511

    2121 Santa Monica Boulevard

    Santa Monica, California 90404

    Read More
  • Publications & Memberships

    Dr. Mark Scholz has contributed to 3 publications.

    Primary androgen deprivation (AD) Followed by active surveillance (AS) for newly diagnosed prostate cancer (PC): A retrospective study.

    Scholz, M. C., Groom, M. K., Kaddis, A. J., Strum, S. B., Jennrich, R. I., Bahn, D. K., Chang, P. J., Becker, L. K., Lam, R. Y.; Prostate. 2013 Jan.

    See more >>

    Primary Intermittent Androgen Deprivation As Initial Therapy for Men with Newly Diagnosed Prostate Cancer.

    Scholz, M.C., Lam, R.Y., Strum, S.B., Labarba, D.J., Becker, L.K., Chang, P., Farhoumand, N., Jennrich, R.I.; Clin Genitourin Cancer. 2011 Dec.

    See more >>

    Prostate-cancer-specific survival and clinical progression-free survival in men with prostate cancer treated intermittently with testosterone-inactivating pharmaceutic...

    Scholz, M.,Lam, R.,Strum, S.,Jennrich, R.,Johnson, H.,Trilling, T.; Urology. 2007 Oct 02.

    See more >>

    Memberships

    American College of Physicians